Many health practitioners daily recommend nutritional products to their patients. Consequently, understanding the state of dietary supplement regulation is critical for patient safety. Currently, the Food and Drug Administration (FDA) does not require premarket approval for dietary supplements before they hit the market. Therefore, this regulatory loophole allows contaminated or mislabeled products to easily reach consumers. To address this risk, the American College of Physicians (ACP) recently published a position paper demanding strict reforms.
The Urgency for Dietary Supplement Regulation
The ACP highlights that over half of American adults consume these unregulated products. However, only a quarter of these individuals receive professional medical advice beforehand. This communication gap increases the risk of severe drug-supplement interactions. Furthermore, physicians often remain unaware of what their patients are taking. Consequently, healthcare providers struggle to identify the root causes of sudden adverse events.
Global Implications and the Indian Landscape
While the ACP focuses on US policies, Indian doctors face remarkably similar challenges. In India, the Food Safety and Standards Authority of India (FSSAI) regulates nutraceuticals as food, not drugs. Specifically, this means manufacturers do not have to undergo rigorous clinical trials before launching products. As a result, the Indian market has seen a surge in adulterated or low-quality supplements. Therefore, Indian clinicians must also counsel patients proactively about the safety of these products.
ACP’s Recommendations for Modernized Frameworks
The ACP paper outlines several key recommendations to modernize the current oversight system. Specifically, the ACP urges Congress to mandate premarket registration and rigorous safety evaluations. Additionally, the FDA must receive adequate funding to strengthen its post-market surveillance. This funding would allow the agency to execute mandatory recalls of unsafe products swiftly. Moreover, the ACP supports creating a public, searchable national database linking ingredients to scientific research.
Best Practices for Clinical Practice
Clinicians play a pivotal role in protecting patients from potential toxicities. Therefore, you should routinely ask patients about their supplement use during every visit. For instance, incorporating standardized dietary questions into electronic health records can improve documentation. However, education must also extend to the patients themselves. Consequently, providing clear, evidence-based guidance helps patients make safer, more informed choices.
Frequently Asked Questions
Q1: Why does the ACP want to change the current dietary supplement regulation?
Currently, dietary supplements do not require FDA approval before going to market. This allows mislabeled and adulterated products to enter the market and endanger public safety.
Q2: How does the lack of regulation affect clinical practice in India?
In India, FSSAI regulates supplements as food. This means they do not undergo clinical trials, making proactive physician inquiry and patient counseling essential for safety.
References
- Cline K et al. Modernizing the Regulatory Framework for Dietary Supplements: A Position Paper From the American College of Physicians. Ann Intern Med. 2026 Jul 14. doi: 10.7326/ANNALS-26-01119. PMID: 42441966.
- Food Safety and Standards Authority of India (FSSAI). Operationalisation of Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations. 2026.
- Thammisetty N, Yetukuri K. Insights and compliance challenges for nutraceutical regulations in Indian market. International Journal of Pharmacy and Pharmaceutical Sciences. 2024.